Beebe, K., Eisner, J. R., Shibata, Y., Davison, J. M., Guo, J., Farhangfar, C. J., … Milla, M. E. (2022). Detailed immunogenomic analysis of high dose IL-2 pharmacodynamic effects: A benchmark for next-generation IL-2-based immunotherapies. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40, pp. E16501–E16501).

Beebe, Kirk, Joel Robert Eisner, Yoichiro Shibata, James M. Davison, John Guo, Carol J. Farhangfar, Farhang Farhangfar, et al. “Detailed immunogenomic analysis of high dose IL-2 pharmacodynamic effects: A benchmark for next-generation IL-2-based immunotherapies.” In JOURNAL OF CLINICAL ONCOLOGY, 40:E16501–E16501, 2022.

Beebe K, Eisner JR, Shibata Y, Davison JM, Guo J, Farhangfar CJ, et al. Detailed immunogenomic analysis of high dose IL-2 pharmacodynamic effects: A benchmark for next-generation IL-2-based immunotherapies. In: JOURNAL OF CLINICAL ONCOLOGY. 2022. p. E16501–E16501.

Beebe, Kirk, et al. “Detailed immunogenomic analysis of high dose IL-2 pharmacodynamic effects: A benchmark for next-generation IL-2-based immunotherapies.” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022, pp. E16501–E16501.

Beebe K, Eisner JR, Shibata Y, Davison JM, Guo J, Farhangfar CJ, Farhangfar F, Uronis JM, Mooney J, Milburn MV, Foureau D, White RL, Amin A, Milla ME. Detailed immunogenomic analysis of high dose IL-2 pharmacodynamic effects: A benchmark for next-generation IL-2-based immunotherapies. JOURNAL OF CLINICAL ONCOLOGY. 2022. p. E16501–E16501.